Back to Network
3
Shared Docs
3
Same-Page
3 / 3
Mentions
Document Mentions (3 shared documents)
2 mentions1 same-page
Page ?Same page
ER TX inhibitors became resistant from a single mutation of the protein T790M within the EGER kinase domain. PED's work caught the attention of Ile. Bert Vogelstein, the lYinzetor of the Ludwig Center for Cancer Genetics and 'Therapeutics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Universi
ig Center for Cancer Genetics and 'Therapeutics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine. Dr. Vogelstein was studying resistance to a colon cancer inhibitor called panitumumab. Enlisting Dr. Nenvak's help. Vogelstein and the PED designed a mathematical
2 mentions1 same-page
Page ?Same page
ER TX inhibitors became resistant from a single mutation of the protein T790M within the EGER kinase domain. PED's work caught the attention of Ile. Bert Vogelstein, the lYinzetor of the Ludwig Center for Cancer Genetics and 'Therapeutics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Universi
ig Center for Cancer Genetics and 'Therapeutics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine. Dr. Vogelstein was studying resistance to a colon cancer inhibitor called panitumumab. Enlisting Dr. Nenvak's help. Vogelstein and the PED designed a mathematical
2 mentions1 same-page
Page ?Same page
FR TK inhibitors became resistant from a single mutation of the protein T790M within the EGFR kinase domain. PED's work caught the attention of Dr. Bert Vogelstein, the Director of the Ludwig Center for Cancer Genetics and Therapeutics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
ig Center for Cancer Genetics and Therapeutics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine. Dr. Vogelstein was studying resistance to a colon cancer inhibitor called panitumumab. Enlisting Dr. Nowak's help, EFTA00583237 Vogelstein and the PED designed a
Sponsored
Mutual Connections (14)
Entities connected to both Bert Vogelstein and Vogelstein
Martin Nowak
PERSON10 w/ Bert·5 w/ Vogelstein
Jeffrey Epstein
PERSON9 w/ Bert·4 w/ Vogelstein
the Program for Evolutionary Dynamics
ORGANIZATION4 w/ Bert·4 w/ Vogelstein
The Final Frontier
ORGANIZATION3 w/ Bert·4 w/ Vogelstein
Johns Hopkins University School of Medicine
ORGANIZATION3 w/ Bert·4 w/ Vogelstein
the National Institute of Cancer
ORGANIZATION3 w/ Bert·4 w/ Vogelstein
Massachusetts General
ORGANIZATION2 w/ Bert·3 w/ Vogelstein
NE
Nenvak
PERSON2 w/ Bert·2 w/ Vogelstein
Journal of Oncology
ORGANIZATION2 w/ Bert·2 w/ Vogelstein
a Biology and Mathematics
ORGANIZATION2 w/ Bert·2 w/ Vogelstein
Johns I Iopkins
ORGANIZATION2 w/ Bert·2 w/ Vogelstein
trials pandit&
ORGANIZATION2 w/ Bert·2 w/ Vogelstein
ET
EGER TX
PERSON2 w/ Bert·2 w/ Vogelstein
TG
the lYinzetor of the Ludwig Center for Cancer Genetics
PERSON2 w/ Bert·2 w/ Vogelstein